Search Results - "Alidzanovic, Jasmina"

Use of the Depression, Anxiety and Stress Scale (DASS-21) Questionnaire to Assess Levels of Depression, Anxiety, and Stress in Healthcare and Administrative Staff in 5 Oncology Institutions in Bosnia and Herzegovina During the 2020 COVID-19 Pandemic by Marijanović, Inga, Kraljević, Marija, Buhovac, Teo, Cerić, Timur, Mekić Abazović, Alma, Alidžanović, Jasmina, Gojković, Zdenka, Sokolović, Emir

“…BACKGROUND Providing oncology services during a pandemic can contribute to mental health challenges among healthcare workers. The present study aimed to…”
Get full text

What is the optimal treatment for appendiceal mass formed after acute perforated appendicitis by Zerem, Enver

“…We read with great interest the editorial article by Meshikhes AWN published in issue 25 of World J Gastroenterol 2011.The article described the advantages of…”
Get full text

Abstract P1-17-02: ZN-c5, an oral selective estrogen receptor degrader (SERD), in women with advanced estrogen receptor-positive (ER+)/human epidermal growth factor receptor 2 negative (HER2-) breast cancer by Kalinksy, Kevin, Abramson, Vandana, Chalasani, Pavani, Linden, Hannah M., Alidzanovic, Jasmina, Layman, Rachel M., Vranješ, Živko, Nangia, Julie R., Crew, Katherine D., Andric, Zoran, Milovic-Kovacevic, Marijana, Trifunovic, Jasna, Suarez, Jose, Suster, Matt, Ptaszynski, Mieke, Mortimer, Joanne

“…Background: Hormone receptor+/HER2- breast cancer is the most common subtype of breast cancer. Resistance to endocrine therapy is a major clinical challenge…”
Get full text

Correlation of cyclin E1 expression and clinical outcomes in a phase 1b dose-escalation study of azenosertib (ZN-c3), a WEE1 inhibitor, in combination with chemotherapy (CT) in patients (pts) with platinum-resistant or refractory (R/R) epithelial ovarian, peritoneal, or fallopian tube cancer (EOC) by Liu, Joyce F., Fu, Siqing, Richardson, Gary Edward, Vranjes, Zivko, Meniawy, Tarek, Shannon, Catherine M., Hamilton, Erika P., Blank, Stephanie V., Mathews, Cara Amanda, Alidzanovic, Jasmina, Ruseva, Rossitza Krasteva, Shi, Qing, Harismendy, Olivier, Ptaszynski, Ann M., Westin, Shannon Neville, Meric-Bernstam, Funda, Thaker, Premal H.

“…5513 Background: Azenosertib (ZN-c3) is a novel, selective, and orally bioavailable WEE1 inhibitor demonstrating single-agent antitumor activity. Azenosertib…”
Get full text

Epidemiological, clinical and pathological characteristics of colorectal cancer in patients treated at the Clinical Center of Tuzla University by Alidžanović, Jasmina, Pavlović, Nada, Salkić, Nermin, Zerem, Enver, Cičkušić, Amra

“…To investigate hospital morbidity and incidence of colorectal cancer (CRC) in the Tuzla Canton between 2000 and 2004, as well as mortality incidence and degree…”
Get full text

2020 consensus guideline for optimal approach to the diagnosis and treatment of HER2-positive breast cancer in Bosnia and Herzegovina by Bešlija, Semir, Gojković, Zdenka, Cerić, Timur, Mekić Abazović, Alma, Marijanović, Inga, Vranić, Semir, Mustedanagić-Mujanović, Jasminka, Skenderi, Faruk, Rakita, Ivanka, Guzijan, Aleksandar, Koprić, Dijana, Humačkić, Alen, Trokić, Danijela, Alidžanović, Jasmina, Efendić, Alma, Šišić, Ibrahim, Drljević, Harun, Bešlagić, Vanesa, Babić, Božana, Pašić, Azra, Ramić, Anela, Mikić, Dijana, Guzin, Zlatko, Karan, Dragana, Buhovac, Teo, Miletić, Dragana, Šečić, Senad, Đozić Šahmić, Azra, Mujbegović, Lejla, Kubura, Alisa, Burina, Mensura, Lalović, Nenad, Dukić, Nikolina, Vladičić Mašić, Jelena, Ćuk, Mirjana, Stanušić, Rajna

“…The HERe2Cure project, which involved a group of breast cancer experts, members of multidisciplinary tumor boards from healthcare institutions in Bosnia and…”
Get full text